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The role mitochondria play in mammary gland development is not fully understood and 
therefore provides an interesting opportunity to study novel interactions. The purpose of this 
project is to elucidate unknown cellular mechanisms in normal mammary epithelial cell 
differentiation. To gain a better understanding of the processes involved in mammary epithelial 
cell differentiation, we differentiated EpH4 mouse mammary epithelial cells in a three-
dimensional, acini model.  Utilizing a three-dimensional model more accurately recapitulates the 
structure of ducts in the mammary gland. Initially, we sought to further understand the role of 
Sim2s in mammary gland ductal development by manipulating Sim2s expression in EpH4 cells. 
We were able to confirm the role Sim2s plays in mammary ductal development. We then 
employed the use of pMitoTimer to trace mitochondrial networks and turnover during acini 
formation. By creating a new cell line with a tetracycline-inducible construct of MitoTimer, we 
established a new way to observe mitochondrial turnover over a longer period. We discovered 
that mitochondria turned over during the course of the acini formation. To understand the role of 
mitochondrial fusion, we silenced the expression of the key mediator of inner mitochondrial 
membrane fusion, Opa1, during acini formation.  We found that Opa1 expression was necessary 
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for acini formation. To understand the role of autophagy in acini formation, we 
pharmacologically inhibited autophagosome degradation with Bafilomycin A1. We have 
previously found that loss of autophagic flux inhibited differentiation-dependent gene expression 
in two-dimensional differentiation of mammary epithelial cells. In conclusion, we have shown 
that mitochondria do in fact adapt in a three-dimensional model of mammary epithelial cell 
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Our lab has found that Singleminded-2s (Sim2s, bHLH/PAS transcription factor) plays an 
essential role in mammary epithelial cell differentiation and is developmentally regulated (1). 
Based on previous research conducted in our lab, we sought to further study mouse mammary 
epithelial cell lines. Our studies in two-dimensional cell culture models prompted us to 
manipulate mitochondrial dynamics to further understand mechanisms of normal development. 
A three-dimensional cell culture model will be used to emulate past research to observe how 
mitochondria adapt in an environment similar to that of normal biology. This research is 
clinically relevant because it is known that disruption of the mitochondria is associated with 
neurodegenerative and metabolic diseases such as Parkinson’s disease, Alzheimer’s, and cancer 
(2). Furthering our understanding of these mechanisms will overall contribute to the current 
studies in our lab and beyond in future medical research. In developing our questions for this 
project, previous research from our lab has shown that mitochondrial adaptation can be observed 
in a two-dimensional cell culture model. 
Sim2s 
 Previous research in our lab has revealed that Sim2s plays a role in normal mouse 
mammary gland development. Figure 1 depicts the relative expression of Sim2s in HC11 mouse 
mammary epithelial cells that were induced to differentiate (1). Compared to undifferentiated 
cells, cells that were induced with prolactin and glucocorticoid to differentiate showed high 
levels of Sim2s expression (1). This suggests that Sim2s plays a role in differentiation as its 
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expression progressively increases during differentiation in mammary epithelial cells. 
 
Figure 1. Sim2s expression in HC11 cells grown in two-dimensional culture (1). 
To understand the effect of Sim2s on development, we sought to knock out and 
overexpress Sim2s in normal mouse mammary epithelial cells. We used a cell line denoted as 
EpH4 from mid-pregnant BALB/c mice that are spontaneously immortalized and 
nontumorigenic (9). By stably transfecting a short hairpin RNA, denoted as shSim2s, into our 
cells, we will knock down Sim2s expression by degrading mRNA associated with Sim2s. We will 
employ a control for this knock down by stably transfecting a plasmid with the same sequence 
but scrambled. To overexpress Sim2s, we will stably transfect a Sim2s plasmid that will allow us 
to observe changes in development. The control for overexpression will be the transfection of an 
empty plasmid. 
Mitochondrial Turnover 
HC11 normal mouse mammary epithelial cells transfected with pMitoTimer allowed us to 
visualize the phenomenon of mitochondrial turnover. These cells were allowed to differentiate 
over a 48 hour time period and imaged at various time points to observe fluorescence. Figure 2 
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shows that transfection of pMitoTimer into the HC11 cells was successful because they 
fluoresced red and green. Images taken at hour 0 through hour 24 show that mitochondria will 
turnover, meaning the mitochondria are being oxidized and targeted for autophagy (3). When the 
cells fluoresce green, this is indicative of newly synthesized cytochrome c oxidase subunit VIII, 
the terminal enzyme in mitochondrial respiration (3). When the cells fluoresce red, cytochrome c 
oxidase subunit VIII is oxidized (3). 
 
Figure 2. HC11 cells time course with pMitoTimer. 
To understand what mechanisms are at work during mitochondrial differentiation in the 
three-dimensional model, a fluorescent probe called pMitoTimer will be used. The pMitoTimer 
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incorporated into the cells will fluoresce either red or green depending on mitochondrial 
conditions, and this will provide information in regards to overall mitochondrial health (3). This 
technique will allow us to visualize changes during differentiation and acini formation. 
Mitochondrial Fusion 
Additionally, our lab has studied the process of mitochondrial fusion in an HC11 two-
dimensional cell culture model. Beta-casein (Csn2) expression is associated with differentiation, 
and detection of Csn2 expression can be used as an indicator of differentiation status in our 
model of mammary epithelial cell differentiation (10). The gene expression of Csn2 gradually 
increases over the course of cellular differentiation and then decreases as cells undergo apoptosis 
(Figure 3).
 
Figure 3. Csn2 expression in differentiating HC11 cells. 
In studying mitochondrial fusion, our lab has shown that optic atrophy 1 (Opa1) is 
involved in differentiation. By silencing Opa1 expression in HC11 cells, we found that Csn2 
expression was decreased at the time of peak differentiation. Figure 4A showed that silencing 
Opa1 was effective and in Figure 4B, silencing Opa1 affected the relative expression of Csn2. 
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Figure 4. (A) Western blot analysis. (B) Expression of Csn2 in relation to presence of siOPA1. 
To observe the role of mitochondrial fusion in a three-dimensional model, a silencing 
RNA targeted to Opa1 will be used. Opa1 is a known mediator of fusion of the inner 
mitochondrial membrane and promotes electron transport chain activity by association of cristae 
structures (4). We aim to see the effects on differentiation in a three-dimensional model after 
silencing the expression of this gene. 
Autophagy 
Autophagy is an essential intracellular recycling system that works to sustain cellular 
metabolism and maintain mitochondrial homeostasis (5). Previous research has demonstrated 
that autophagy is required for functional differentiation; therefore, we aim to further understand 
the mechanism of autophagy in differentiation (7-8). To observe the role of autophagy in 
differentiation, we will pharmacologically inhibit autophagy with Bafilomycin A1. 
Objectives 
The project aims to answer the following objectives to contribute to known information 
about differentiation in mammary gland development.  
 To observe the effect Sim2s has on mammary epithelial cell differentiation. 
 To use a fluorescent reporter probe to observe possible intracellular changes in 
mitochondria. 
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 To discover if mitochondrial fusion is required for differentiation by silencing the gene 
associated with fusion control. 
 To discover if autophagy is required for differentiation by pharmacologically inhibiting 
autophagic flux.  
The results from each objective will contribute to the known mitochondrial mechanisms we 
understand and will provide new information regarding the mechanisms in a model similar to 



















MATERIALS AND METHODS 
 
Cell Lines 
 In the following protocols, the EpH4 cell line of normal mouse mammary epithelial cells 
will be used. These cells are gift from Margret Neville at the University of Colorado Health 
Science Center in Denver. The cells are maintained in a normal growth media consisting of 
DMEM F12, fetal bovine serum, gentamycin, insulin, and mouse epidermal growth factor 
(EGF). 
For retroviral transfection, Phoenix-AMPHO 293T cells were purchased from ATCC. 
The cells were maintained as recommended in DMEM supplemented with 10% fetal bovine 
serum and 1% penicillin/streptomycin.  
Acini Formation Protocol 
The objectives will be answered by employing a three-dimensional cell culture model 
using EpH4 cells. This protocol is adapted from a paper that studied MCF10A human mammary 
epithelial cells. This protocol is advantageous because it allows for easier observation of the 
acini structures and provides a suitable environment for larger acini structures to grow (6). The 
basic structure for the acini formation protocol will primarily follow the recommendations for 
human mammary epithelial cells and will take place over the course of 10 days (6).  
The cells were plated in a multi-well plate. A single layer of growth factor reduced 
Matrigel was placed at the bottom of the well and allowed to solidify. A single-cell suspension of 
EpH4 cells was then placed on top of the Matrigel in an assay medium containing 2% Matrigel, 
2% horse serum, 50μg/ml gentamycin, 10μg/ml insulin, 2μg/ml hydrocortisone, and 6μg/ml 
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prolactin. The cells were maintained in an incubator at 37°C for 10 days. The assay media was 
changed every 2 to 4 days. Figure 5A diagrams the process. Furthermore, in Figure 5B, the 
course of expected normal proliferation is diagramed. This progression will be documented. 
  
 
Figure 5. Growth of acini in Matrigel. Diagrams from J. Debnath et al (6). 
From these basic steps, the protocols will differ regarding which objective we aim to 
answer. To address Sim2s, EpH4 cells with Sim2s knocked down and overexpressed will be 
grown for acini formation. For the next objective, the protocol will be run to observe changes in 
the mitochondria using a fluorescent reporter probe, pMitoTimer, in the acini formation. In the 
third objective, we will use a silencing RNA, siOPA1, to observe inhibition of mitochondrial 
fusion during acini formation. For the last objective, the protocol will undergo drug-therapy with 
Bafilomycin A1 to see if autophagy is required for differentiation in the cell culture model. 
Transient Transfection 
 This protocol was utilized for transfecting pMitoTimer and siOPA1 constructs into the 
EpH4 cells. A mixture of Optim-MEM, Genejuice, and pMitoTimer was added dropwise to the 





 This protocol was utilized for Sim2s and for the tetracycline-inducible MitoTimer 
construct. A mixture of Optim-MEM, Genejuice, and desired plasmid were added to a plate of 
Phoenix-AMPHO 293T cells and incubated overnight. The next day this viral media was 
replaced with a EpH4 media-10%DMEM media mixture. On day 3, the viral media was filtered 
and polybrene was added. This viral media was added to the EpH4 cells and spun for an hour to 
enhance the success of the transfection. This process was repeated on day 4. On day 5, the media 
was changed on the EpH4 cells, and selection of cells with puromycin began the following day. 



















EpH4 Acini Growth Progression 
 To observe how the EpH4 cells would adapt and grow with Matrigel, images were taken 
with a ZEISS Discovery microscope over the course of the 10 day protocol. These cells were 
transfected with pMitoTimer, which did not have any observed effects on the development of the 
acini formation. Figure 6 shows the progression from day 1 to day 9. 
 
Figure 6. Progression of acini growth. 
Sim2s with Acini Formation 
 EpH4 cells were previously transfected with overexpression and knock down constructs 
of Sim2s in order to observe the effect on acini growth. On day 14 of the protocol, the images in 
Figure 7 were taken with a ZEISS Discovery microscope.  
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Figure 7. Sim2s and EpH4 acini growth. (A) shControl for knock down of Sim2s. (B) shSim2s for 
knock down of Sim2s. (C)  Control for Sim2s overexpression. (D) Sim2s-flag for Sim2s 
overexpression. 
pMitoTimer with Acini Formation 
First, we sought to determine the longevity of the pMitoTimer plasmid in the EpH4 cells. 
For this, we selected three different time points to insert the plasmid during acini growth. This 
would help determine the best technique to ensure the plasmid could be observed and whether 
the plasmid could be inserted into the cells during acini growth. The cells underwent three time-
point transfections in order to observe any differences in response. The pMitoTimer plasmid was 
transiently transfected into the cells prior to plating (pre-treatment), on day 1, and on day 4 of 
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acini growth. Images from each time point were collected. The cells were observed under a 
ZEISS Discovery microscope and images were recorded throughout the protocol.  
Once the best way to transfect the MitoTimer into the cells was determined, the acini 
protocol was repeated with only pre-treated cells. Acini growth was recorded for day 1 through 
day 3. The growth and fluorescence were recorded. The data was not completely collected 
throughout the 10 day protocol because on day 4 the cells died. This was concluded to be due to 
lack of media in the wells from evaporation overnight, and unfortunately, the data was not 
conclusive. Additionally, during this experiment the fluorescent bulb on the Discovery 
microscope burnt out and images for fluorescence were not able to be recorded after day 3. 
Figure 8 shows images captured from the Discovery microscope of the acini growth and the 
fluorescence of the mitochondria in cells pre-treated with pMitoTimer.  
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Figure 8. (A) Day 1 of EpH4 acini growth with pMitoTimer. (B) Day 3 of EpH4 acini growth 
with pMitoTimer. (C) Day 1 of EpH4 growth with red fluorescence. (D) Day 3 of EpH4 acini 
growth with red fluorescence. 
Tetracycline-Inducible Construct of MitoTimer 
 Since transient transfection is not a stable model, we turned to a tetracycline inducible 
model for the cells. EpH4 cells were retrovirally transfected with a tetracycline-inducible 
construct of MitoTimer, pTRE-tight-MitoTimer. Figure 9 shows the successful incorporation of 
the plasmid into EpH4 cells grown in a monoculture.  
 
Figure 9. (A) Fluorescence 3 hours after doxycycline treatment. (B) Fluorescence 24 hours after 
doxycycline treatment.  
siOpa1 with Acini Formation 
 The siOpa1 was transiently transfected in the EpH4 cells prior to plating in Matrigel. The 
cells were transiently transfected with three different silencing RNAs in order to target three 
regions of Opa1. These silencing RNAs are denoted as siNEG for our control, siOpa1 A, siOpa1 
17 
B, and siOpa1 C. RNA was harvested from the cells when there was a noticeably different 
phenotype shown in the growing acini as seen in Figure 10. 
 
Figure 10. (A) siNEG Control in EpH4 cells on day 1. (B) siOpa1 A in EpH4 cells on day 1. (C) 
siOpa1 B in EpH4 cells on day 1. (D) siOpa1 C in EpH4 cells on day 1. (E) siNEG Control in 
EpH4 cells on day 4. (F) siOpa1 A in EpH4 cells on day 4. (G) siOpa1 B in EpH4 cells on day 4. 
(H) siOpa1 C in EpH4 cells on day 4. 
By quantitative PCR analysis, the relative expression of Opa1 and Csn2 was analyzed as 
shown in Figure 11. 
 
Figure 11. Opa1 and Csn2 expression in EpH4 cells. 
 











































Bafilomycin A1 with Acini Formation 
 EpH4 cells were treated with Bafilomycin A1 at different time points in the acini 
protocol. One group of cells was treated prior to plating the cells in Matrigel (pre-treated) with 
1nM of Bafilomycin A1. One group was treated with Bafilomycin A1 after plating in Matrigel. 
There was a control group that was treated with DMSO as a vehicle control. Figure 12 shows the 
differences in acini growth of the EpH4 cells. 
 
Figure 12. (A) Bafilomycin A1 pre-treated EpH4 cells on day 1. (B) Bafilomycin A1 EpH4 cells 
on day 1. (C) DMSO control EpH4 cells on day 1. (D) Bafilomycin A1 Pre-treated EpH4 cells 














We know from previously published work from our lab that Sim2s plays a role in 
mammary epithelial development (1). We also know from ongoing research in the lab that 
mitochondrial turnover, fusion, and autophagy are essential mechanisms for mammary epithelial 
cell differentiation. The three-dimensional, acini model allowed for us to observe these known 
phenomena at a new angle, which had not previously been done before in our lab. The acini 
model better emulates normal cell biology and furthered our understanding of the cellular 
mechanisms behind mammary epithelial cell differentiation. 
To initially test the three-dimensional acini model, we examined the effect of Sim2s on 
EpH4 cell differentiation. In Figure 7A and B, we knocked down the expression of Sim2s and 
observed the resulting acini growth. The control cells developed large, hollow acini structures, as 
expected. The Sim2s knock-down cells were considerably smaller and lacked the formation of a 
lumen. This suggests that Sim2s is essential for mammary gland formation, because the lack of 
Sim2s failed to produce the alveolar structure typical of a mouse mammary gland. Furthermore, 
in Figure 7C and D, EpH4 cells overexpressing Sim2s were subjected to acini formation. The 
control cells showed well-developed, large, hollow acini structures. The Sim2s overexpressing 
EpH4 cells formed hollow acini structures that were larger overall than the control. This suggests 
that Sim2s contributes to and enhances the development of mammary alveoli. To address our 
question, these data support past research of the developmental role of Sim2s in mammary ductal 
development. 
20 
Mitochondrial turnover in acini formation was observed when pMitoTimer was 
transiently transfected into the EpH4 cells. The transfection of pMitoTimer and growth of acini 
was performed twice to select a time point for transfection that would be successful and to 
determine if successful transfection could be repeated. For the pre-treated cells, it was 
determined that pMitoTimer was consistently observed in the cells on days 1 through 4. For the 
cells that underwent the transfection on days 1 and 4 there was no evidence of successful 
transfection. The day 1 and day 4 cells did not fluoresce under the microscope, and it was 
concluded that the cells would not uptake the plasmid as the cells began to differentiate. For 
replication of this experiment, we can conclude that transient transfection prior to plating is best 
for the successful uptake of pMitoTimer into the cells. Additionally, the cells did not fluoresce 
past day 5. This was not surprising because as the mitochondria turnover, this tag gets cycled out 
of the cell. In a second run of the experiment with only pMitoTimer pre-treated cells, the 
experiment was not completed. This protocol stills shows that transfecting prior to plating in 
Matrigel was a successful technique and allowed for the mitochondrial turnover to be observed 
for at least three days. Due to equipment failure, the fluorescence was not able to be observed 
past day 3 of growth. To address our question, this information shows that mitochondria do in 
fact turn over during the course of differentiation in a three-dimensional model.  
 As pMitoTimer is cycled out of the mitochondria as they turnover, we turned to a more 
permanent model. The transient transfection, though successful, limits our ability to observe 
turnover throughout the full differentiation of EpH4 cells. By utilizing a tetracycline-inducible 
version of MitoTimer, we were able to successfully create a stable EpH4 cell line. These cells are 
denoted as pTRE-tight-MitoTimer EpH4 cells. We found that treating cells with 1μM of 
doxycycline could initiate the expression of MitoTimer. We treated the cells with doxycyclin and 
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observed their fluorescence after 3 and 24 hours. Although the cells shown in Figure 9 are in 
two-dimensional culture, future steps would be to utilize these cells in the three-dimensional, 
acini model. By having this permanent construct in the cells, we will be able to observe 
mitochondrial turnover over a longer period during cell differentiation.  
 Mitochondrial fusion is an essential process in two-dimensional cellular differentiation. 
In Figure 10, we saw significant acini growth. It was expected that silencing Opa1 would affect 
the development of the acini structures. Using quantitative PCR analysis, we found that the 
transfection was not successful due to remaining expression of Opa1 in all three variants of 
siOpa1. The growth was expected to be impaired between day 1 and day 6 of differentiation. 
One anomaly that we saw was there were cells that did not form acini structures and grew as if 
they were in a two-dimensional culture. This can be seen in Figure 10B where the EpH4 cells 
both formed acini and a flat growth pattern. We harvested these cells for RNA when we saw 
cells that did not form acini structures, which we hypothesized was indicative of the silencing of 
Opa1. However, as we saw from the quantitative PCR analysis, that was not the case. The cells 
that failed to form acini structures was possibly due to lack of Matrigel where they were plated. 
This prevents the cells from establishing a base for an acini structure to develop. Though the data 
here is not conclusive for what we sought to answer, this data does point us in a new direction for 
this phenomena. As with pMitoTimer, it might be better to try this with a tetracycline-inducible 
model. This would establish a more permanent model that would allow for the observation of the 
effects of silencing Opa1 over the course of differentiation. This would also allow us to confirm 
the role Opa1 plays in normal mammary epithelial cell differentiation. 
 Autophagy is another key cellular mechanism in the differentiation of mammary 
epithelium. Our images in Figure 12, show the results of treating EpH4 cells with Bafilomycin 
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A1 and allowing them to grow in Matrigel. The difference in day 1 of pre-treated cells (Figure 
12A) versus day 6 (Figure 12D) is interesting, because the hollow acini structures were not 
expected to be seen. Figure 12B and E show the EpH4 cells that were treated with Bafilomycin 
A1 after plating. These cells formed acini structures, and on day 6 the cells from each group 
were harvested for RNA. The RNA quantity was too low to continue to quantitative PCR and 
was therefore inconclusive. This was suspected to be due to the low cell count plated in Matrigel. 
Based on these results, a greater number of cells will be used in future repetitions of this 
experiment. Another way of answering this question would be to employ a silencing RNA in a 
fashion similar to what we tried with Opa1. Autophagy related 5 (Atg5) is known mediator of 
autophagy, and by silencing its expression in EpH4 cells, we could observe how autophagy plays 
a role in differentiation (5). 
 This was the first time our lab looked at EpH4 cell differentiation in a three dimensional 
model. Utilizing the acini growth protocol helped us to visualize the process of differentiation in 
a model that is similar to normal cell biology of a mouse mammary gland. This information is 
important because it confirms the known cellular mechanisms that we have seen previously in 
the published literature and in current ongoing research in the lab. The data found in this project 
also provides future directions for studying cellular mechanisms in mammary epithelial cell 
differentiation. From this project, we were able to confirm that mitochondria due in fact adapt in 
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